CCZ1 and infection: They subsequently established CCZ1 knockout cell clones using CRISPR/Cas9 and generated vascular organoids from these clones, discovering that the infection efficiency of EBOV and MARV on CCZ1‐deficient vascular organoids was indeed reduced [44].